Réf. 1: Compounds, I. of M. (US) P. on D. A. and R.(2000) Vitamin C. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium,and Carotenoids. National Academies Press (US).
Dawodu, A. et al. (2012). Maternal vitamin Dstatus: effect on milk vitamin D content and vitamin D status of breastfeedinginfants. Adv. Nutr. 3, 353–361 (2012).
Moretti, D. et al.(2006.) Iron status and foodmatrix strongly affect the relative bioavailability of ferric pyrophosphate inhumans. Am. J. Clin. Nutr. 83, 632–638.
Olafsdottir, A. S., et al. (2001). Fat‑solublevitamins in the maternal diet, influence of cod liver oil supplementation andimpact of the maternal diet on human milk composition. Ann. Nutr. Metab.45, 265–272 .
Padayatty, S. J. et al. (2003) Vitamin C as anantioxidant: evaluation of its role in disease prevention. J. Am. Coll.Nutr. 22, 18–35 .
Sandström, B. (2001) Micronutrientinteractions: effects on absorption and bioavailability. Br. J. Nutr. 85Suppl 2, S181–S185.
Scientific Opinion on Dietary Reference Valuesfor vitamin C | EFSA.
EFSA Journal.https://www.efsa.europa.eu/en/efsajournal/pub/3418
Update of the tolerable upper intake level forvitamin D for infants | EFSA.
EFSA Journal.https://www.efsa.europa.eu/en/efsajournal/pub/5365
Réf. 2: Akira S., et al. (2006). Pathogen Recognition and Innate Immunity. Cell,124(4), 783–801. doi:10.1016/j.cell.2006.02.015
AkkermanR., et al. (2019). Non-digestible carbohydrates in infant formula assubstitution for human milk oligosaccharide functions: Effects on microbiotaand gut maturation. CriticalReviews in Food Science and Nutrition, 59(9), 1486–1497. doi:10.1080/10408398.2017.1414030
AlizadehA., et al. (2016). Thepiglet as a model for studying dietary components in infant diets: Effects ofgalacto-oligosaccharides on intestinal functions. British Journal ofNutrition, 115(4), 605–618. doi:10.1017/S0007114515004997
AshleyC., et al. (2012).Growth and tolerance of infants fed formula supplemented with polydextrose(PDX) and/or galactooligosaccharides (GOS): Double-blind, randomized,controlled trial. Nutrition Journal, 11(1), 38.
doi:10.1186/1475-2891-11-38
Austin S., et al. (2018). Determination of2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula. Molecules,23(10), 2650. doi:10.3390/molecules23102650
AzadM.B., et al. (2018).Human Milk Oligosaccharide Concentrations Are Associated with Multiple Fixedand Modifiable Maternal Characteristics, Environmental Factors, and FeedingPractices. The Journal of Nutrition, 148(11), 1733–1742. doi:10.1093/jn/nxy175
BaiY., et al. (2018). FucosylatedHuman Milk Oligosaccharides and N-Glycans in the Milk of Chinese MothersRegulate the Gut Microbiome of Their Breast-Fed Infants during DifferentLactation Stages. mSystems, 3(6), doi:10.1128/msystems.00206-18
BenX.M., et al. (2004). Supplementation of milk formula withgalacto-oligosaccharides improves intestinal micro-flora and fermentation interm infants. Chinese Medical Journal, 117(6), 927–931.
BenX.M., et al. (2008). Lowlevel of galacto-oligosaccharide in infant formula stimulates growth ofintestinal Bifidobacteria and Lactobacilli. World Journal ofGastroenterology, 14(42), 6564. doi:10.3748/wjg.14.6564
BergerB., et al. (2020). LinkingHuman Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk ToRequire Antibiotics. mBio, 11(2), e03196-19. doi:10.1128/mBio.03196-19
BergerP. K., et al. (2022). Associations of Human Milk Oligosaccharideswith Infant Brain Tissue Organization and Regional Blood Flow at 1 Month ofAge. Nutrients, 14(18), 3820. doi:10.3390/nu14183820
Bienenstock J., et al.(2013). Fucosylated but NotSialylated Milk Oligosaccharides Diminish Colon Motor Contractions. PLoSONE, 8(10), e76236. doi:10.1371/journal.pone.0076236
BodeL. (2006). Recent Advances on Structure, Metabolism, and Function of Human MilkOligosaccharides. The Journal of Nutrition, 136(8),2127–2130. doi:10.1093/jn/136.8.2127
BodeL. (2012). Human milkoligosaccharides: Every baby needs a sugar mama. Glycobiology, 22(9),1147–1162. doi:10.1093/glycob/cws074
BodeL., et al. (2016).Overcoming the limited availability of human milk oligosaccharides: Challengesand opportunities for research and application. Nutrition Reviews,74(10), 635–644. doi:10.1093/nutrit/nuw025
BoshevaM., et al. (2022). Infant Formula With a Specific Blend of Five Human MilkOligosaccharides Drives the Gut Microbiota Development and Improves GutMaturation Markers: A Randomized Controlled Trial. Frontiers inNutrition, 9, 920362. doi:10.3389/fnut.2022.920362
CachoN.T., et al. (2017). Innate Immunity and Breast Milk. Frontiersin Immunology, 8, 584. doi:10.3389/fimmu.2017.00584
ChaturvediP., et al. (2001).Fucosylated human milk oligosaccharides vary between individuals and over thecourse of lactation. Glycobiology, 11(5), 365–372. doi:10.1093/glycob/11.5.365
ChengL., et al. (2020). Human Milk Oligosaccharides Differently Modulate GobletCells Under Homeostatic, Proinflammatory Conditions and ER Stress. MolecularNutrition & Food Research, 64(5), 1900976. doi:10.1002/mnfr.201900976
Chichlowski M., et al. (2023). Early development of infant gutmicrobiota in relation to breastfeeding and human milk oligosaccharides. Frontiersin Nutrition, 10, 1003032. doi:10.3389/fnut.2023.1003032
ChonanO., et al. (1995). Effect ofGalactooligosaccharides on Calcium Absorption in Rats. Journal ofNutritional Science and Vitaminology, 41(1), 95–104. doi:10.3177/jnsv.41.95
Chonan O., et al. (1996). The effectof 6’-galactooligosaccharides on bone mineralization of rats adapted todifferent levels of dietary calcium. International Journal for Vitamin andNutrition Research, 66(3), 244–249.
Chung H., et al. (2012). Gut ImmuneMaturation Depends on Colonization with a Host-Specific Microbiota. Cell,149(7), 1578–1593. doi:10.1016/j.cell.2012.04.037
DinleyiciM., et al. (2023). Functional effects of human milk oligosaccharides (HMOs). GutMicrobes, 15(1), 2186115. doi:10.1080/19490976.2023.2186115
DonovanS.M., et al. (2016).Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity. Annalsof Nutrition and Metabolism, 69(Suppl. 2), 41–51. doi:10.1159/000452818
EFSAPanel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the essentialcomposition of infant and follow-on formulae. (o. J.). EFSA Journal,(2014;12(7):3760). doi:10.2903/j.efsa.2014.3760
ESPGHAN Committee on Nutrition; Braegger C., et al.(2011). Supplementation of Infant Formula With Probiotics and/or Prebiotics: ASystematic Review and Comment by the ESPGHAN Committee on Nutrition. Journalof Pediatric Gastroenterology and Nutrition, 52(2), 238–250. doi:10.1097/MPG.0b013e3181fb9e80
FallaniM., et al. (2010).Intestinal Microbiota of 6‐week‐old Infants Across Europe: Geographic Influence Beyond Delivery Mode,Breast‐feeding, and Antibiotics. Journalof Pediatric Gastroenterology and Nutrition, 51(1), 77–84. doi:10.1097/MPG.0b013e3181d1b11e
FanaroS., et al. (2009).Galacto‐oligosaccharides Are Bifidogenic andSafe at Weaning: A Double‐blind Randomized Multicenter Study. Journalof Pediatric Gastroenterology and Nutrition, 48(1), 82–88. doi:10.1097/MPG.0b013e31817b6dd2
GarridoD., et al. (2011). OligosaccharideBinding Proteins from Bifidobacterium longum subsp. Infantis Reveal aPreference for Host Glycans. PLoS ONE, 6(3),e17315. doi:10.1371/journal.pone.0017315
GiovanniniM., et al. (2014).Prebiotic Effect of an Infant Formula Supplemented withGalacto-Oligosaccharides: Randomized Multicenter Trial. Journal of theAmerican College of Nutrition, 33(5), 385–393. doi:10.1080/07315724.2013.878232
Goehring K. C., et al. (2016). Similar to Those Who Are Breastfed, Infants Feda Formula Containing 2′-Fucosyllactose Have Lower Inflammatory Cytokines in aRandomized Controlled Trial. The Journal of Nutrition, 146(12),2559–2566. doi:10.3945/jn.116.236919
GonzálezR., et al. (2008).Differential Transcriptional Response of Bifidobacterium longum to HumanMilk, Formula Milk, and Galactooligosaccharide. Applied and EnvironmentalMicrobiology, 74(15), 4686–4694. doi:10.1128/AEM.00122-08
Han,S. M., et al. (2020). Do Human Milk Oligosaccharides Protect Against InfantAtopic Disorders and Food Allergy? Nutrients, 12(10),3212. doi:10.3390/nu12103212
He Y., et al. (2014). Human colostrumoligosaccharides modulate major immunologic pathways of immature humanintestine. Mucosal Immunology, 7(6), 1326–1339. doi:10.1038/mi.2014.20
HegarB., et al. (2019). TheRole of Two Human Milk Oligosaccharides, 2′-Fucosyl-lactose andLacto-N-Neotetraose, in Infant Nutrition. Pediatric Gastroenterology,Hepatology & Nutrition, 22(4), 330. doi:10.5223/pghn.2019.22.4.330
HillD. R., et al. (2021). Multifunctional Benefits of Prevalent HMOs: Implicationsfor Infant Health. Nutrients, 13(10), 3364. doi:10.3390/nu13103364
Holscher H. D., et al. (2014). Human Milk OligosaccharidesInfluence Maturation of Human Intestinal Caco-2Bbe and HT-29 Cell Lines. TheJournal of Nutrition, 144(5), 586–591. doi:10.3945/jn.113.189704
Holst A. Q., et al. (2023).Infant Formula Supplemented with Five Human Milk Oligosaccharides Shifts theFecal Microbiome of Formula-Fed Infants Closer to That of Breastfed Infants. Nutrients, 15(14), 3087. doi:10.3390/nu15143087
Jantscher‑KrennE., et al. (2012). Human milk oligosaccharides reduce Entamoebahistolytica attachment and cytotoxicity in vitro. BritishJournal of Nutrition, 108(10), 1839–1846. doi:10.1017/S0007114511007392
Jeurink P. V., et al. (2013). Human milk: A source of more life than weimagine. Beneficial Microbes, 4(1), 17–30. doi:10.3920/BM2012.0040
Kajzer J., et al. (2016). GastrointestinalTolerance of Formula Supplemented with Oligosaccharides. The FASEBJournal, 30(S1). doi:10.1096/fasebj.30.1_supplement.671.4
KoletzkoB., et al. (2013).Compositional Requirements of Follow-Up Formula for Use in Infancy:Recommendations of an International Expert Group Coordinated by the EarlyNutrition Academy. Annals of Nutrition and Metabolism, 62(1),44–54. doi:10.1159/000345906
KongnumK., et al. (2020). Impactsof Prebiotic-Supplemented Diets and Breastmilk on Population and Diversity ofLactobacilli Established in Thai Healthy Infants. CurrentMicrobiology, 77(7), 1191–1202. doi:10.1007/s00284-020-01920-9
LinA. E., et al. (2017). Human milk oligosaccharides inhibit growth of group BStreptococcus. Journal of Biological Chemistry, 292(27),11243–11249. doi:10.1074/jbc.M117.789974
Ma L., et al. (2018). Lactational changes in the humanmilk oligosaccharide concentration in Chinese and Malaysian mothers’ milk. InternationalDairy Journal, 87, 1–10. doi:10.1016/j.idairyj.2018.07.015
Marriage B. J., et al. (2015). Infants Fed a Lower Calorie Formula With 2 ′FL Show Growth and 2 ′ FL Uptake Like Breast‐Fed Infants. Journal of Pediatric Gastroenterology and Nutrition,61(6), 649–658. doi:10.1097/MPG.0000000000000889
MatsukiT., et al. (2016). Infantformula with galacto-oligosaccharides (OM55N) stimulates the growth ofindigenous bifidobacteria in healthy term infants. BeneficialMicrobes, 7(4), 453–462. doi:10.3920/BM2015.0168
Moukarzel S., et al. (2017). Human MilkOligosaccharides and the Preterm Infant. Clinics in Perinatology,44(1), 193–207. doi:10.1016/j.clp.2016.11.014
NaardingM. A. (2005). Lewis Xcomponent in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ Tlymphocytes. Journal of Clinical Investigation, 115(11),3256–3264. doi:10.1172/JCI25105
Ottino-González,J., et al. (2024).Consumption of different combinations of human milk oligosaccharides in thefirst 6 mo of infancy is positively associated with early cognition at 2 y ofage in a longitudinal cohort of Latino children. The American Journal ofClinical Nutrition, 120(3), 593–601. doi:10.1016/j.ajcnut.2024.07.020
Paganini D., et al. (2017). Consumption of galacto-oligosaccharidesincreases iron absorption from a micronutrient powder containing ferrousfumarate and sodium iron EDTA: A stable-isotope study in Kenyan infants. TheAmerican Journal of Clinical Nutrition, 106(4), 1020–1031. doi:10.3945/ajcn.116.145060
PaganiniD., et al. (2017).Prebiotic galacto-oligosaccharides mitigate the adverse effects of ironfortification on the gut microbiome: A randomised controlled study in Kenyaninfants. Gut, 66(11), 1956–1967. doi:10.1136/gutjnl-2017-314418
Parschat, K., et al. (2021). Clinical Evaluation of 16-Week Supplementationwith 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety,and Effect on Growth. Nutrients, 13(8), 2871. doi:10.3390/nu13082871
Plaza‑DíazJ., et al. (2018). Human Milk Oligosaccharides andImmune System Development. Nutrients, 10(8), 1038. doi:10.3390/nu10081038
PuccioG., et al. (2017). Effectsof Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: ARandomized Multicenter Trial. Journal of Pediatric Gastroenterology andNutrition, 64(4), 624–631. doi:10.1097/MPG.0000000000001520
Reverri E. J., et al. (2018). Review of the Clinical Experiencesof Feeding Infants Formula Containing the Human Milk Oligosaccharide2′-Fucosyllactose. Nutrients, 10(10), 1346. doi:10.3390/nu10101346
RijnierseA., et al. (2011). Food-derivedoligosaccharides exhibit pharmaceutical properties. European Journal ofPharmacology, 668, S117–S123. doi:10.1016/j.ejphar.2011.07.009
Ruiz-PalaciosG. M., et al. (2003). Campylobacter jejuni BindsIntestinal H(O) Antigen (Fucα1, 2Galβ1,4GlcNAc), and Fucosyloligosaccharides of Human Milk Inhibit Its Binding andInfection. Journal of Biological Chemistry, 278(16),14112–14120. doi:10.1074/jbc.M207744200
Santos E. F. D., et al. (2011). Dietary galactooligosaccharidesincrease calcium absorption in normal and gastrectomized rats. Revista do Colégio Brasileiro deCirurgiões, 38(3),186–191. doi:10.1590/S0100-69912011000300009
Scholtens P. A. M. J., et al. (2012). The Early Settlers: Intestinal Microbiology inEarly Life. Annual Review of Food Science and Technology, 3(1),425–447. doi:10.1146/annurev-food-022811-101120
ShoafK., et al. (2006).Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichiacoli to Tissue Culture Cells. Infection and Immunity, 74(12),6920–6928. doi:10.1128/IAI.01030-06
SierraC., et al. (2015). Prebioticeffect during the first year of life in healthy infants fed formula containingGOS as the only prebiotic: A multicentre, randomised, double-blind andplacebo-controlled trial. European Journal of Nutrition, 54(1),89–99. doi:10.1007/s00394-014-0689-9
Sinclair H. R., et al. (2009). Galactooligosaccharides (GOS) Inhibit Vibriocholerae Toxin Binding to Its GM1 Receptor. Journal of Agriculturaland Food Chemistry, 57(8), 3113–3119. doi:10.1021/jf8034786
Sjögren Y. M., et al. (2009). Influence of early gut microbiota onthe maturation of childhood mucosal and systemic immune responses: Gutmicrobiota and immune responses. Clinical & Experimental Allergy,39(12), 1842–1851. doi:10.1111/j.1365-2222.2009.03326.x
SmilowitzJ. T., et al. (2014).Breast Milk Oligosaccharides: Structure-Function Relationships in the Neonate. AnnualReview of Nutrition, 34(1), 143–169. doi:10.1146/annurev-nutr-071813-105721
StanislawskiM. A., et al. (2018).Gut Microbiota in the First 2 Years of Life and the Association with Body MassIndex at Age 12 in a Norwegian Birth Cohort. mBio, 9(5),e01751-18. doi:10.1128/mBio.01751-18
StewartC. J., et al. (2018). Temporal development of the gut microbiome inearly childhood from the TEDDY study. Nature, 562(7728),583–588. doi:10.1038/s41586-018-0617-x
StiversonJ., et al. (2014). Prebiotic Oligosaccharides: Comparative Evaluation Using InVitro Cultures of Infants’ Fecal Microbiomes. Applied and EnvironmentalMicrobiology, 80(23), 7388–7397. doi:10.1128/AEM.02200-14
TanakaM., et al. (2017).Development of the gut microbiota in infancy and its impact on health in laterlife. Allergology International, 66(4), 515–522. doi:10.1016/j.alit.2017.07.010
Thurl S., et al. (2010). Variation of human milkoligosaccharides in relation to milk groups and lactational periods. BritishJournal of Nutrition, 104(9), 1261–1271. doi:10.1017/S0007114510002072
Thurl S., et al. (2017). Systematicreview of the concentrations of oligosaccharides in human milk. NutritionReviews, 75(11), 920–933. doi:10.1093/nutrit/nux044
UrashimaT., et al. (2012). ThePredominance of Type I Oligosaccharides Is a Feature Specific to Human BreastMilk. Advances in Nutrition, 3(3), 473S-482S. doi:10.3945/an.111.001412
UrashimaT., et al. (2018). HumanMilk Oligosaccharides as Essential Tools for Basic and Application Studies onGalectins. Trends in Glycoscience and Glycotechnology, 30(172),SE51–SE65. doi:10.4052/tigg.1734.1SE
· VandenplasY., et al. (2015). Oligosaccharides in infant formula: More evidence tovalidate the role of prebiotics. British Journal of Nutrition, 113(9),1339–1344. doi:10.1017/S0007114515000823
Vandenplas Y., et al. (2018). Human MilkOligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) inInfant Formula. Nutrients, 10(9), 1161. doi:10.3390/nu10091161
Vatanen T., et al. (2018). The human gut microbiome inearly-onset type 1 diabetes from the TEDDY study. Nature, 562(7728),589–594. doi:10.1038/s41586-018-0620-2
Watson D., et al. (2013). Selectivecarbohydrate utilization by lactobacilli and bifidobacteria. Journal ofApplied Microbiology, 114(4), 1132–1146. doi:10.1111/jam.12105
Weaver C. M., et al. (2011). Galactooligosaccharides Improve MineralAbsorption and Bone Properties in Growing Rats through Gut Fermentation. Journalof Agricultural and Food Chemistry, 59(12), 6501–6510. doi:10.1021/jf2009777
Whisner C. M., et al. (2013). Galacto-oligosaccharides increase calciumabsorption and gut bifidobacteria in young girls: A double-blind cross-overtrial. British Journal of Nutrition, 110(7), 1292–1303. doi:10.1017/S000711451300055X
WicińskiM., et al. (2020).Human Milk Oligosaccharides: Health Benefits, Potential Applications in InfantFormulas, and Pharmacology. Nutrients, 12(1), 266. doi:10.3390/nu12010266
Williams T., et al. (2014). Tolerance ofFormulas Containing Prebiotics in Healthy, Term Infants. Journal ofPediatric Gastroenterology and Nutrition, 59(5), 653–658. doi:10.1097/MPG.0000000000000513
XuG., et al. (2017). Absolute Quantitation of Human Milk Oligosaccharides RevealsPhenotypic Variations during Lactation. The Journal of Nutrition, 147(1),117–124. doi:10.3945/jn.116.238279
Réf. 3: Yaron S., et al., J Pediatr GastroenterolNutr, 2013 56(4):376-81; Yao M., et al., JPGN, 2014 59 (4):440-448;Hageman J.H.J., et al., International Dairy Journal, 2019 92: 37-49.
Réf. 4: Forsyth S., et al., Proc Nutr Soc,2017 76(4):568-573.
Réf. 5: Singhal A., et al., Am J Clin Nutr,2008 87(6):1785-1792; Sanchez L.C., et al., Nutritional Neuroscience,2009 12 (1): 2-8
Réf. 6: Zeisel S. H., da Costa K.A., NutritionReviews, 2009 67(11):615-623.
Wu Guoyaou, Amino Acids, 202052:329-360.
European Food Safety Authority, EFSAJournal, 2014 12(7):3760.
